Eli Lilly Says Cymbalta Users Can't Reopen Axed Case

Law360 (February 13, 2018, 3:24 PM EST) -- Eli Lilly and Co. urged a California federal court Monday not to reopen a proposed class action alleging the drugmaker hid the withdrawal risks of the antidepressant Cymbalta, saying the proposed class voluntarily dismissed their suit knowing that a U.S. Supreme Court decision could block them from appealing.

Eli Lilly said that when the Cymbalta users voluntarily dismissed their original suit with the intention to appeal, based on Ninth Circuit precedent at the time, they knew that other circuits disagreed with the practice and that Microsoft...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.